Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma

Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma Publisher Pubmed

Gheysarzadeh A¹ ; Ansari A¹ ; Emami MH² ; Razavi AE³ ; Mofid MR¹

Show Affiliations

1. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
2. Gastrointestinal and Hepatobiliary Diseases Research Center, Poursina Hakim Research Institute for Health Care Development, Isfahan, Iran
3. Iran National Tumor Bank, Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Source: Pancreatology Published:2019

Abstract

Background: Low-density lipoprotein receptor-Related Protein-1 (LRP-1) has been reported to involve in tumor development. However, its role in pancreatic cancer has not been elucidated. The present study was designed to evaluate the expression of LRP-1 in Pancreatic Ductal Adenocarcinoma Cancer (PDAC) as well as its association with prognosis. Methods: Here, 478 pancreatic cancers were screened for suitable primary PDAC tumors. The samples were analyzed using qRT-PCR, western blotting, and Immunohistochemistry (IHC) staining as well as LRP-1 expression in association with clinicopathological features. Results: The relative LRP-1 mRNA expression was up-regulated in 82.3% (42/51) of the PDAC tumors and its expression (3.72 ± 1.25) was significantly higher than that in pancreatic normal margins (1.0 ± 0.23, P < 0.05). This up-regulation was stage dependent (P < 0.05). A similar pattern of LRP-1 protein expression was discovered (P < 0.05). The high expression of LRP-1 in the PDAC tissues was strongly correlated with the low survival time (P = 0.001), TNM classification (P = 0.001), low differentiations status (P = 0.001), lymphatic invasion (P = 0.01) and Perineural Invasion (PNI) status (P = 0.001). Conclusions: Our finding for the first time revealed that LRP-1 expression inversely associated with poor prognosis and PNI in PDAC tumor. © 2019

Style	Citing Format
MLA	Gheysarzadeh A, et al.. "Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma." Pancreatology, vol. 19, no. 3, 2019, pp. 429-435.
APA	Gheysarzadeh A, Ansari A, Emami MH, Razavi AE, Mofid MR (2019). Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma. Pancreatology, 19(3), 429-435.
Chicago	Gheysarzadeh A, Ansari A, Emami MH, Razavi AE, Mofid MR. "Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma." Pancreatology 19, no. 3 (2019): 429-435.
Harvard	Gheysarzadeh A et al. (2019) 'Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma', Pancreatology, 19(3), pp. 429-435.
Vancouver	Gheysarzadeh A, Ansari A, Emami MH, Razavi AE, Mofid MR. Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma. Pancreatology. 2019;19(3):429-435.
BibTex	@article{ author = {Gheysarzadeh A and Ansari A and Emami MH and Razavi AE and Mofid MR}, title = {Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma}, journal = {Pancreatology}, volume = {19}, number = {3}, pages = {429-435}, year = {2019} }
RIS	TY - JOUR AU - Gheysarzadeh A AU - Ansari A AU - Emami MH AU - Razavi AE AU - Mofid MR TI - Over-Expression of Low-Density Lipoprotein Receptor-Related Protein-1 Is Associated With Poor Prognosis and Invasion in Pancreatic Ductal Adenocarcinoma JO - Pancreatology VL - 19 IS - 3 SP - 429 EP - 435 PY - 2019 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract